Glenmark Pharma's Stock Reaches 52-Week High, Outperforms Sector and Market
Glenmark Pharmaceuticals, a largecap pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on October 15, 2024. The stock is currently trading at Rs.1830.05, with a 'Hold' rating from MarketsMojo. The company has shown a positive trend in the past few days and has outperformed the sector and overall market with a 1-year growth of 129.09%.
Glenmark Pharmaceuticals ., a largecap pharmaceutical company, has recently reached a new milestone as its stock price touched a 52-week high on October 15, 2024. The stock is currently trading at Rs.1830.05, which is also an all-time high for the company.
According to MarketsMOJO, a leading stock market analysis platform, the stock is currently rated as 'Hold'. This rating is based on the company's performance in the market and its potential for future growth.
In terms of performance, Glenmark Pharma has underperformed the sector by -0.73% today. However, the stock has shown a positive trend in the past few days, with a consecutive gain of 2 days before falling today.
The moving averages for Glenmark Pharma are also positive, with the stock trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong performance by the company in the market.
In comparison to the overall market performance, Glenmark Pharmaceuticals has shown an impressive 1-year performance of 129.09%, while the Sensex has only grown by 23.96% in the same period. This showcases the company's strong growth and potential in the pharmaceutical industry.
Glenmark Pharmaceuticals is a leading player in the pharmaceutical and drugs industry, with a largecap size. With its recent achievement of reaching a 52-week high, the company continues to showcase its strength and potential in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
